Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 1,001

Document Document Title
WO/2004/014929A1
New compounds and methods for the preparation of combinatorial libraries of potentially biologically active compounds are based on monosaccharides of formula (I) being a derivative of a furanose or pyranose form of a monosaccharide.  
WO2003078627A3
A building block having the dual capabilities of transferring the genetic information e.g. by recognising an encoding element and transferring a functional entity to a recipient reactive group is diclosed. The building block can be desig...  
WO2003078050A3
A building block having the dual capabilities of recognising an encoding element and transferring a functional entity to a recipient reactive group is disclosed. The building block may be used in the generation of a single complex or lib...  
WO/2003/102001A1
The invention relates to the preparation of monolithic silica under mild conditions from alkoxysilanes derived from sugars, sugar acids, sugar alcohols and polysaccharides including glycerol, sorbitol, mannose and dextran. Unlike the com...  
WO2003078626A3
A building block having the dual capabilities of transferring the genetic information e.g. by recognising an encoding element and transferring a functional entity to a recipient reactive group is disclosed. The building block can be desi...  
WO/2003/097647A1
The invention relates to vitamin-mitomycin conjugates, to a method of using the conjugates to selectively eliminate a population of pathogenic cells in a host animal harboring the pathogenic cells, and to a method of preparation of the c...  
WO/2003/078626A2
A building block having the dual capabilities of transferring the genetic information e.g. by recognising an encoding element and transferring a functional entity to a recipient reactive group is disclosed. The building block can be desi...  
WO/2003/078627A2
A building block having the dual capabilities of transferring the genetic information e.g. by recognising an encoding element and transferring a functional entity to a recipient reactive group is diclosed. The building block can be desig...  
WO/2003/078050A2
A building block having the dual capabilities of recognising an encoding element and transferring a functional entity to a recipient reactive group is disclosed. The building block may be used in the generation of a single complex or lib...  
WO/2003/074544A1
The present invention provides methods and compositions useful for coding and decoding complex mixtures of test units. These methods and compositions use coding and decoding oligonucleotides that comprise standard nucleobases and also no...  
WO/2003/055898A1
A modified nucleoside analogue having the formula (I): P - S - B - L - R where: P is a 5' triphosphate or analogue or derivative thereof; S is a substituted or unsubstituted five- or six-membered sugar, sugar analogue or acyclo sugar ana...  
WO2003008430A3
This invention relates to porphyrin compounds used to destroy or impair the functioning of a target biological material in photodynamic therapy, in particular against virus, tumoral cells, bacteria, tumorous tissues. The invention also r...  
WO/2003/042284A1
A ssacharide residue-functional organopolycarbosiloxane containing at least two monosaccharide or polysaccharide groups per molecule in which a specific site on the monosaccharide or polysaccharide is bonded to silicon through a thioethe...  
WO/2003/042283A1
A saccharide residue-functional organopolysiloxane containing at least two monosaccharide or polysaccharide groups per molecule in which a specific site on the monosaccharide or polysaccharide is bonded to silicon through a thioether bon...  
WO/2003/026674A1
Cobalamin transport proteins are administered in combination with cobalamin coupled to a diagnostic or pharmaceutically active agents to increase the extent of absorption of the diagnostic or pharmaceutically active agent. Cobalamin tran...  
WO/2003/022860A1
Preparation of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids.  
WO/2003/018602A1
The inventive ferrocene mannose derivatives have the following general structural formula: Wherein n=1-6. Said compositions are capable to activate the killing of intracellularly localised microorganisms.  
WO/2003/016325A1
A modified metal ion compound reduced in industrially undesirable properties inherent in metal ion compounds, such as deliquescence, reducing ability, oxidizing ability, and poor solubility in water&semi a process for producing the produ...  
WO/2003/008430A2
This invention relates to porphyrin compounds used to destroy or impair the functioning of a target biological material in photodynamic therapy, in particular against virus, tumoral cells, bacteria, tumorous tissues. The invention also r...  
WO2002055530A3
An agent, composition and method for the treatment, prophylaxis and/or diagnosis of proliferative disorders, which is highly and efficiently absorbed at the site of abnormal cellular proliferation is disclosed.  
WO2002018405A3
The present invention provides methods for the chemical synthesis of nucleosides and derivatives thereof, including 2'-amino, 2'-N-phthaloyl, 2'-O-methyl, 2'-O-silyl, 2'-OH nucleosides, C-nucleosides, nucleoside phosphoramidites, C-nucle...  
WO/2002/102820A1
Nucleoside derivatives as building blocks for templated libraries are described.  
WO/2002/098896A1
A novel process, which is industrially favorable and nondetrimental to the environment, for producing methylcobalamin useful as drugs, etc. More particularly speaking, a process for producing methylcobalamin characterized by comprising r...  
WO/2002/095840A1
Organic circuit elements and methods are disclosed. An organic circuit element includes a plurality of members, each of which includes an oligonucleotide duplex. The plurality of members includes at least one donor member for receiving c...  
WO/2002/087632A1
The invention relates to a wide variety of different methods and compositions that find use in high throughput screening applications utilizing magnetic resonance imaging (MRI) contrast agents.  
WO2002042318A3
The present invention is directed to neutron capture agents, such as a molecule comprising Boron-10 or Gadolinium-157, for the treatment, prophylaxis and/or diagnosis of a proliferative disorder via a direct or indirect attachment to a c...  
WO2001091807A3
The invention provides, in a general sense, a new labeling strategy employing <99m>Tc chelated with ethylenedicysteine (EC). EC is conjugated with a variety of ligands and chelated to <99m>Tc for use as an imaging agent for tissue-specif...  
WO/2002/055530A2
An agent, composition and method for the treatment, prophylaxis and/or diagnosis of proliferative disorders, which is highly and efficiently absorbed at the site of abnormal cellular proliferation is disclosed.  
WO/2002/051854A1
A process for producing a highly purified metal complex of an aminooligosaccharide derivative by effectively removing impurities, by-products, excess eluates, etc. generated in the step of synthesizing the aminooligosaccharide derivative...  
WO2001092283A3
The invention provides cobalamin derivatives linked to a cardiovascular agent, as well as pharmaceutical compositions comprising the compounds and methods for using the compounds in treatment or diagnosis of a cardiovascular disease.  
WO2001092288A3
The invention provides cobalamin derivatives linked to an antibiotic and/or an imaging agent, as well as pharmaceutical compositions comprising the compounds and methods for using the compounds in treatment or diagnosis of a microbial in...  
WO/2002/042318A2
The present invention is directed to neutron capture agents, such as a molecule comprising Boron-10 or Gadolinium-157, for the treatment, prophylaxis and/or diagnosis of a proliferative disorder via a direct or indirect attachment to a c...  
WO/2002/018405A2
The present invention provides methods for the chemical synthesis of nucleosides and derivatives thereof, including 2'-amino, 2'-N-phthaloyl, 2'-O-methyl, 2'-O-silyl, 2'-OH nucleosides, C-nucleosides, nucleoside phosphoramidites, C-nucle...  
WO/2002/014309A1
The invention relates to perfluoroalkyl-containing complexes comprising sugar residues of the general formula (I), wherein R represents a mono- or oligosaccharide residue bound in the 1-OH or 1-SH position, R¿f? represents a perfluorate...  
WO/2002/002588A1
Carbosilane dendrimer compounds containing sugar chains in the chemical structure and having verotoxin-neutralizing and antiviral activities. Also, carbosilane dendrimer compounds having terminal sialyl lactose to which viruses are speci...  
WO/2001/096356A1
Antisense molecules which act on both directions of the inhibition and restoration of the expression of a gene function and are capable of on/off switching appropriately depending on the external environment; and a method of reversibly c...  
WO/2001/092283A2
The invention provides cobalamin derivatives linked to a cardiovascular agent, as well as pharmaceutical compositions comprising the compounds and methods for using the compounds in treatment or diagnosis of a cardiovascular disease.  
WO/2001/092288A2
The invention provides cobalamin derivatives linked to an antibiotic and/or an imaging agent, as well as pharmaceutical compositions comprising the compounds and methods for using the compounds in treatment or diagnosis of a microbial in...  
WO/2001/091807A2
The invention provides, in a general sense, a new labeling strategy employing ?99m¿Tc chelated with ethylenedicysteine (EC). EC is conjugated with a variety of ligands and chelated to ?99m¿Tc for use as an imaging agent for tissue-spec...  
WO2001005769A3
Heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality of Formula (I) wherein (a) represents a 5- or 6- membered heterocyclic aromatic ring in which (i) each of X1-X4 is O, S, NR', N, CR" or a bond; (ii) ...  
WO2001014339A3
Heterocyclic aromatic amides (HAA) according to Formula (I) wherein X1-X4, M, Z, and A are herein defined. The invention also encompasses hydrates, salts and complexes thereof. These compounds are useful as antifungal agents.  
WO/2001/070724A1
The present invention relates to a complex comprising one or more radioisotopes selected from the group consisting of ?99m¿Tc, ?188¿Re and ?186¿Re chelated to a glucose derivative having an intramolecular nitrogen or sulfur atom, whic...  
WO/2001/042271A1
A novel industrially excellent process for the production of methylcobalamin useful as drug or the like, characterized by methylating cyanocobalamin or hydroxocobalamin in the presence of a reducing agent and a water-soluble methylating ...  
WO/2001/035966A1
Inflammation is affected by topical application of a boron containing compound/complex in which a central tetrahedral boron atom is covalently bound to four ligands. At least one of the ligands preferably includes an oxygen, nitrogen, ca...  
WO/2001/028592A1
The invention provides cobalamin derivatives which are useful for medical treatment and diagnosis.  
WO/2001/014339A2
Heterocyclic aromatic amides (HAA) according to Formula (I) wherein X¿1?-X¿4?, M, Z, and A are herein defined. The invention also encompasses hydrates, salts and complexes thereof. These compounds are useful as antifungal agents.  
WO/2001/005769A2
Heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality of Formula (I) wherein (a) represents a 5- or 6- membered heterocyclic aromatic ring in which (i) each of X¿1?-X¿4? is O, S, NR', N, CR' or a bond;...  
WO2000020428A9
One aspect of the present invention relates to differentially protected glycosyl phosphates. Another aspect of the present invention relates to the preparation of glycosyl phosphates from glycal precursors. In another aspect of the prese...  
WO/2000/057887A1
The present invention is directed to salt-free and essentially salt-free $i(p)-boronophenylalanine-carbohydrate or $i(p)-boronophenylalanine-polyol complexes, as well as methods for making such compounds. In addition, the present inventi...  
WO/2000/056740A1
The present invention provides arylboronic acid reagents useful for incorporation into modified oligonucleotides and polynucleotides. The modified oligonucleotides and polynucleotides thus produced are useful in bioconjugation reactions ...  

Matches 101 - 150 out of 1,001